Browse by author
Lookup NU author(s): Professor Sanjay PandanaboyanaORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2017 International Hepato-Pancreato-Biliary Association Inc.Background The aim of this systematic review was to evaluate perioperative and long term outcomes in patients who underwent PVE prior to liver resection for colorectal liver metastases. Methods A systematic search of PubMed, MEDLINE, Embase and the Cochrane library was performed in accordance with PRISMA guidelines. Studies including patients who underwent liver resection with and without PVE (N-PVE) were included. Results Thirteen studies including 1345 were included of which 539 patients had PVE and 806 had N-PVE. Eight studies reported that from a total of 450 patients who underwent PVE, 136 (30%) did not proceed to liver resection. In 114 (84%) patients this was due to disease progression. The postoperative morbidity was 42% (n = 151) after PVE and 10% (n = 35) developed postoperative liver failure after liver resection. Median overall survival, reported in all studies, was 38.9 months and 45.6 months respectively, following resection with PVE and N-PVE. The median disease free survival, reported in eight studies, was 15.7 (PVE) and 21.4 (N-PVE) months respectively. Conclusion Following PVE 70% of patients proceed to liver resection, with a 10% risk of postoperative liver failure. Tumour progression after PVE was the predominant reason for not proceeding to liver resection.
Author(s): Ironside N, Bell R, Bartlett A, McCall J, Powell J, Pandanaboyana S
Publication type: Review
Publication status: Published
Journal: HPB
Year: 2017
Volume: 19
Issue: 7
Pages: 559-566
Print publication date: 01/07/2017
Online publication date: 21/04/2017
Acceptance date: 01/03/2017
ISSN (print): 1365-182X
ISSN (electronic): 1477-2574
Publisher: Elsevier B.V.
URL: https://doi.org/10.1016/j.hpb.2017.03.003
DOI: 10.1016/j.hpb.2017.03.003
PubMed id: 28438427
